Skip to content

King Pharmaceuticals KG Legacy Reinsurance — Net premiums written

Other segment segments

AmTrust Legacy Segment
$1.88M
Diversified Legacy Segment
$775K

Similar metrics at other companies

Everest Group logo
EGLegacy — Net written premiums
$89M-83.9%
Everest Group logo
EGLegacy — Premiums Written, Gross
$135M-80.3%
Axis Capital Holders logo
AXSReinsurance — Net premiums written
$613.96M-13.0%
SiriusPoint logo
SPNTReinsurance — Net premiums written
$281.85M+2.1%
SiriusPoint logo
SPNTReinsurance — Net written premium
$235.7M-12.2%
Chubb logo
CBGlobal Reinsurance — Net premiums written
$363M-11.0%

Other financials

Income statement

See full
Revenue$10.2M+1,112%
Net income-$7.4M-1,786%
EPS (diluted)-$0.96-586%

Balance sheet

See full
Cash & equivalents$62.2M+1,724%
Total debt$176.7M
Total equity$121.4M+2,773%
Total assets$964.2M

Cash flow

See full
Operating cash flow-$15.1M-1,628%

Valuation

See full
Market cap$70.42M-67.6%
Enterprise value$184.93M-50.0%
P/E1.2×
P/S1.6×-24.3×

Profitability

See full
Net margin131.5%

Returns & leverage

See full
Return on equity90.8%
Debt / equity1.5×

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PremiumsWrittenNet.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's legacy reinsurance — net premiums written.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is King Pharmaceuticals's legacy reinsurance — net premiums written?
King Pharmaceuticals (KG) reported legacy reinsurance — net premiums written of $2.65M in Q1 2026.
What does legacy reinsurance — net premiums written mean?
Represents the gross premiums written by the legacy reinsurance segment minus the portion ceded to other reinsurers. This figure provides a clearer view of the risk the segment retains on its own balance sheet.